AGP Executive Report
Last update: 8 hours agoRare-disease drug access in Brazil: Knight Therapeutics says ANVISA expedited approval brings NIKTIMVO® (axatilimab) to patients with chronic graft-versus-host disease after failure of at least two therapies, and it has also launched TAVALISSE® (fostamatinib) for chronic immune thrombocytopenia—both moves aimed at expanding treatment options in Latin America. Climate + health resilience in the Amazon: In Brazil’s Pará, an Indigenous riverine community installed solar-powered water pumps to prepare for El Niño-linked drought, improving access to clean water for 36 families. Regional health diplomacy: Cayman’s health minister attended PAHO-linked CARICOM health meetings focused on health security, noncommunicable diseases, HIV, cancer care, digital health, and Universal Health Coverage. Public health watch: Reports of a suspected pneumonic plague death in Russia triggered global monitoring and quarantines, with officials urging calm while details remain disputed. Care access + policy pressure: A study on immigration enforcement in the U.S. found foreign-born patients cut ER visits during raids, raising concerns about delayed care and worse outcomes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
